TherapeuticsMD logo
TherapeuticsMD TXMD
$ 1.36 2.26%

Quarterly report 2024-Q2
added 08-12-2024

report update icon

TherapeuticsMD Balance Sheet 2011-2024 | TXMD

Annual Balance Sheet TherapeuticsMD

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

3.68 M -29.3 M 125 M 159 M 44.5 M -88.2 M -127 M -132 M -64.7 M -51.4 M -54.2 M 2.04 M 2.02 M

Long Term Debt

6.53 M 7.37 M 188 M 238 M 195 M 73.4 M - - - - - 3.59 M -

Long Term Debt Current

1.47 M 1.39 M 1.36 M 2.25 M 1.5 M - - - - - - - -

Total Non Current Liabilities

- - - 246 M 204 M 73.4 M - - - - - 3.74 M -

Total Current Liabilities

6.85 M 46.8 M 253 M 59.2 M 53 M 41.1 M 13.3 M 15 M 10.7 M 10.7 M 7.32 M 3.51 M 3.15 M

Total Liabilities

14 M 55.3 M 263 M 306 M 257 M 114 M 13.3 M 15 M 10.7 M 10.7 M 7.32 M 7.25 M 3.15 M

Deferred Revenue

- - - - - - - - - 523 K 1.6 M 1.14 M -

Retained Earnings

-950 M -939 M -1.05 B -879 M -695 M -519 M -387 M -310 M -220 M -135 M -80.5 M -52.1 M -17 M

Total Assets

43.3 M 90.5 M 169 M 182 M 266 M 212 M 143 M 142 M 73.7 M 59.1 M 62 M 5.82 M 1.44 M

Cash and Cash Equivalents

4.33 M 38.1 M 64.9 M 80.5 M 161 M 162 M 127 M 132 M 64.7 M 51.4 M 54.2 M 1.55 M 126 K

Book Value

29.3 M 35.1 M -93.6 M -124 M 9.2 M 97.5 M 130 M 127 M 63.1 M 48.4 M 54.7 M -1.43 M -1.71 M

Total Shareholders Equity

29.3 M 35.1 M -93.6 M -124 M 9.2 M 97.5 M 130 M 127 M 63.1 M 48.4 M 54.7 M -1.43 M -1.71 M

All numbers in USD currency

Quarterly Balance Sheet TherapeuticsMD

2024-Q2 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

- - 6.74 M 6.94 M 7.14 M 7.37 M 93.6 M 90.8 M 203 M 188 M 172 M 175 M 179 M 238 M 238 M 238 M 238 M 195 M 195 M 195 M 195 M 73.4 M 73.4 M 73.4 M 73.4 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - 246 M 246 M 253 M 252 M 204 M 204 M 204 M 204 M - 73.3 M 73.1 M - - - - - - - - - - - - - - - - - - - - - 3.74 M 3.74 M 3.74 M 3.74 M - - - -

Total Liabilities

12.5 M 14 M 22.4 M 22.5 M 27.6 M 55.3 M 182 M 172 M 274 M 263 M 267 M 260 M 249 M 306 M 306 M 306 M 306 M 257 M 257 M 257 M 257 M 114 M 114 M 114 M 114 M 13.3 M 13.3 M 13.3 M - - 12.5 M 9.34 M - 10.7 M 12.9 M 10.7 M 11.8 M 10.7 M - 10.7 M 10.7 M 7.32 M 6.39 M 4.6 M 7.32 M 7.36 M 7.25 M 7.25 M 7.25 M 3.15 M 3.15 M 3.15 M 3.15 M

Deferred Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

-951 M -950 M -949 M -945 M -943 M -939 M -1.02 B -988 M -1.1 B -1.05 B -1.01 B -961 M -918 M -879 M -879 M -879 M -879 M -695 M -695 M -695 M -695 M -519 M -519 M -519 M -519 M -387 M -387 M -387 M -387 M -310 M -310 M -310 M -310 M -220 M -220 M -220 M -220 M -135 M -135 M -135 M -135 M -80.5 M -80.5 M -80.5 M -80.5 M -52.1 M -52.1 M -52.1 M -52.1 M -17 M -17 M -17 M -17 M

Total Assets

40.1 M 43.3 M 50.5 M 53.7 M 59.6 M 90.5 M 134 M 146 M 133 M 169 M 210 M 211 M 239 M 182 M 182 M 182 M 182 M 266 M 266 M 266 M 266 M 212 M 212 M 212 M 212 M 143 M 143 M 143 M 143 M 142 M 142 M 142 M 142 M 73.7 M 73.7 M 73.7 M 73.7 M 59.1 M 59.1 M 59.1 M 59.1 M 62 M 62 M 62 M 62 M 5.93 M 5.82 M 5.82 M 5.82 M 1.44 M 1.44 M 1.44 M 1.44 M

Cash and Cash Equivalents

5.23 M 4.33 M 10.2 M 13.7 M 17.2 M 38.1 M 65.1 M 65.1 M 65.1 M 65.1 M 105 M 111 M 138 M 80.5 M 80.5 M 80.5 M 80.5 M 161 M 161 M 161 M 161 M 162 M 162 M 162 M 162 M 127 M 127 M 127 M 127 M 132 M 132 M 132 M 132 M 64.7 M 64.7 M 64.7 M 64.7 M 51.4 M 51.4 M 51.4 M 51.4 M 54.2 M 54.2 M 54.2 M 54.2 M 1.55 M 154 K 1.33 M 195 K 126 K 154 K 126 K 126 K

Book Value

27.7 M 29.3 M 28.1 M 31.2 M 32 M 35.1 M -48.3 M -26.1 M -141 M -93.6 M -57.4 M -49.1 M -9.48 M -124 M -124 M -124 M -124 M 9.2 M 9.2 M 9.2 M 9.2 M 97.5 M 97.5 M 97.5 M 97.5 M 130 M 130 M 130 M 143 M 142 M 130 M 133 M 142 M 63.1 M 60.8 M 63.1 M 62 M 48.4 M 59.1 M 48.4 M 48.4 M 54.7 M 55.6 M 57.4 M 54.7 M -1.43 M -1.43 M -1.43 M -1.43 M -1.71 M -1.71 M -1.71 M -1.71 M

Total Shareholders Equity

27.7 M 29.3 M 28.1 M 31.2 M 32 M 35.1 M -48.3 M -26.1 M -141 M -93.6 M -57.4 M -49.1 M -9.48 M -124 M -124 M -124 M -124 M 9.2 M 9.2 M 9.2 M 9.2 M 97.5 M 97.5 M 97.5 M 97.5 M 130 M 130 M 130 M 130 M 127 M 127 M 127 M 127 M 63.1 M 63.1 M 63.1 M 63.1 M 48.4 M 48.4 M 48.4 M 48.4 M 54.7 M 54.7 M 54.7 M 54.7 M -1.43 M -1.43 M -1.43 M -1.43 M -1.71 M -1.71 M -1.71 M -1.71 M

All numbers in USD currency